Vivo Capital
$1.2B Assets Reported
55 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| ERAS | Erasca Inc | 12,151,480 | $197M | 16.3% |
| PRAX | Praxis Precision Medicines | 338,895 | $109M | 9.1% |
| TERN | Terns Pharmaceuticals Inc | 1,334,418 | $70M | 5.8% |
| TRVI | Trevi Therapeutics Inc | 5,094,668 | $61M | 5.1% |
| DBVT | DBV Technologies SA | 2,667,569 | $56M | 4.6% |
| CMPX | Compass Therapeutics Inc | 9,545,466 | $50M | 4.2% |
| TNGX | Tango Therapeutics Inc | 2,154,780 | $45M | 3.7% |
| SABS | SAB Biotherapeutics Inc | 11,420,000 | $44M | 3.6% |
| CRVS | Corvus Pharmaceuticals Holdings | 2,805,816 | $41M | 3.4% |
| DRUG | Bright Minds Biosciences Inc | 557,172 | $41M | 3.4% |
Track Vivo Capital's 13F portfolio: $1.2B in reported holdings, 55 positions. Top holdings, AUM, and quarterly changes on SentiSense.